Background and Purpose-Endothelial nitric oxide exerts a variety of protective effects on endothelial cells and blood vessels, and therefore the nitric oxide synthase 3 gene (NOS3) is a logical candidate gene for stroke susceptibility. Methods-We used the population-based Stroke Prevention in Young Women case-control study to assess the association of five NOS3 polymorphisms in 110 cases (46% black) with ischemic stroke and 206 controls (38% black), 15 to 44 years of age. Polymorphisms included 3 single nucleotide polymorphisms (SNPs) in the promoter region (Ϫ1468 TϾA, Ϫ922 GϾA, Ϫ786 TϾC), 1 SNP in exon 7 (G894T), and 1 insertion/deletion polymorphism within intron 4. Results-Significant associations with both the Ϫ922 GϾA and Ϫ786 TϾC SNPs with ischemic stroke were observed in the black, but not the white, population. This association was attributable to an increased prevalence of the Ϫ922 A allele (ORϭ3.0, 95% CIϭ1.3 to 6.8; Pϭ0.005) and the -786 T allele (ORϭ2.9, 95% CIϭ1.3 to 6.4; Pϭ0.005) in cases versus controls. These 2 SNPs were in strong linkage disequilibrium (DЈϭ1.0), making it impossible to determine, within the confines of this genetic study, whether 1 or both of these polymorphisms are functionally related to NOS3 expression. Two sets of haplotypes were also identified, 1 of which may confer an increased susceptibility to stroke in blacks, whereas the other appears to be protective. 
F
amilial aggregation and twin studies provide evidence for a strong genetic component to ischemic stroke risk, particularly for early-onset cases. [1] [2] [3] [4] [5] [6] Endothelial nitric oxide synthase (NOS3) is a logical candidate gene because of its ability to generate NO, which plays a central role in the maintenance of vascular homeostasis, including regulation of the cerebral circulation. NO is also a potent vasodilator 7 and inhibits platelet aggregation. 8 Impaired endothelial-mediated vasodilation is a common feature of many vascular risk factors, and experimental evidence strongly supports a role for impaired NO-dependent vasomotor reactivity in the pathophysiology of stroke. 9, 10 Association Studies with NOS3 and ischemic stroke have been conducted exclusively in older populations and typically included only 1 or a few SNPs genotyped in various ethnic groups. [11] [12] [13] These studies have yielded conflicting results. To
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further characterize the role of NOS3 in ischemic stroke, we evaluated 5 polymorphisms among black and white cases and controls in the Stroke Prevention in Young Women Study (SPYW).
Materials and Methods

Population
The SPYW study is a population-based, case-control study initiated to examine risk factors for ischemic stroke. Both cases and their comparison group (controls) were identified from a study area that included all of Maryland except the far Western panhandle, Washington DC, and southern portions of both Pennsylvania and Delaware. Cases and controls were recruited between February 26, 1992 and January 1, 1996. Institutional review committees at collaborating institutions approved the study and participants gave informed consent.
The baseline characteristics of the SPYW population are shown in Table 1 . Cases (51 black, 59 white) were women 15 to 44 years of age with a first cerebral infarction, who were identified by discharge surveillance at all 59 hospitals in the study area or through direct referral by regional neurologists. All stroke cases were adjudicated by 2 neurologists. The methods for discharge surveillance, chart abstraction, case adjudication, and assignment of probable and possible underlying causes have been described previously. 14, 15 Recruitment within 1 year of stroke was required for participation. Controls (78 black, 128 white) were identified by random-digit dialing and included women without a history of stroke, frequency matched by age and geographic region of residence to the cases.
Hypertension, diabetes mellitus, and angina or myocardial infarction were determined by asking the participant (or her proxy when the participant was unable to answer) whether she had ever been told by a physician that she had the condition. Similarly, age, race, and current smoking status were determined by participant or proxy report. Total cholesterol was measured according to standard practice. 16 
Genotyping of NOS3 Polymorphisms
The Ϫ1468 TϾA, Ϫ922 GϾA, and Ϫ786 TϾC single nucleotide polymorphisms (SNPs) were genotyped using the MassARRAY genotyping system (Sequenom, Inc, San Diego, Calif). For the intron 4 tandem repeat, polymerase chain reaction was performed followed by separation on 2% agarose gels. The exon 7 SNP was genotyped by polymerase chain reaction followed by restriction fragment length polymorphism analysis using the enzyme BanII.
Genetic Analysis
Each of the biallelic polymorphisms was analyzed by comparing differences in genotype frequencies between cases and controls, stratified by race. 2 tests assuming a recessive model were performed in instances where only a small number of homozygotes existed for the rare allele. Hardy-Weinberg equilibrium and intermarker linkage disequilibrium (LD) was calculated using SnpAnalyzer, an enhanced, Web-based version of the SNP-Analysis package (Kruglyak available at http://www.fhcrc.org/labs/kruglyak/ Downloads). Haplotypes were determined using the PHASE computer program. 17 
Results
Five polymorphisms in NOS3 were examined (Figure) . All SNPs were in Hardy-Weinberg equilibrium. Using multiple pair-wise tests, significant LD was observed between four genotyped polymorphisms in the white population (DЈϭ0.79 to 1.00). Lower DЈ values were observed between all SNPs and G894T (DЈϭ0.41 to 0.76). However, in the black population, only the promoter SNPs were in LD with each other (DЈϭ0.82 to 1.00).
Two promoter SNPs, Ϫ922 GϾA and Ϫ786 TϾC, were significantly associated with stroke susceptibility in blacks when compared by genotype and allele (Pϭ0.005 to 0.017; Table 2 ). The odds ratio for blacks was 3.0 (95% CI, 1.3 to 6.8) with the Ϫ922 AA genotype and 2.9 (95% CI, 1.3 to 6.4) with the Ϫ786 TT genotype. This association was independent of hypertension status, because stroke susceptibility was still significantly associated after adjusting for this dichotomous variable (Pϭ0.030). No significant associations were observed with interaction analysis with "current smoking" status in either population.
Inspection of haplotypes revealed that the same haplotype was most common in both blacks and whites (TATbG; Table 3 ). One haplotype was significantly different between black cases and controls. This haplotype, AGCaG, was not observed in any cases but was observed in 8% (nϭ13) of control participants (Pϭ0.001). Further inspection of haplotypes revealed potential "risk" and "protective" haplotypes, if 1 or 2 SNPs were ignored. For example, the TATxG haplotype (where x is any allele) occurred in 59% of the black cases versus 44% of controls (Pϭ0.02). Conversely, the AGCxx haplotype occurred in 10% of black cases versus 24% of controls (Pϭ0.004).
Discussion
NO is an important and well-characterized vasodilator, with homeostasis of NO essential in maintaining vascular tone in the systemic and cerebral circulation. We observed significant associations with the Ϫ922 and Ϫ786 promoter SNPs of the NOS3 gene and susceptibility to stroke in black women. black women with the risk genotype for either SNP (Ϫ922 AA or Ϫ786 TT) had Ϸ3ϫ the risk of stroke compared with women with the alternative genotypes. This effect was not observed in the white women.
There is a paucity of comparable data by which to assess our main finding that black women with the risk genotypes were at an increased risk of stroke. Two British studies have examined the association of NOS3 polymorphisms with stroke in elderly white populations. In an earlier study, the exon 7 G894T SNP was not found to be associated with a combined case population of ischemic stroke and transient ischemic attacks, nor with the degree of carotid stenosis. 11 A subsequent study by the same group found an association between Ϫ786 TϾC and intron 4 insertion/deletion haplo- types and lacunar infarction in the absence of associated ischemic leukoaraiosis and a protective effect of the intron 4 "a" allele. 12 We did not observe this protective effect in our sample. Although our allele frequencies for both the single SNPs and haplotypes are very similar for the overall white case and control groups, unfortunately, our sample size is too small to examine stroke subtypes to directly compare studies. There are several potential explanations for the differing associations in different populations. First, these differences could be attributable to chance, although this is unlikely, given the small probability values and the small number of tested polymorphisms. Second, population-stratification bias may be involved. Because our results indicate that blacks have a higher prevalence of the Ϫ922 AA and Ϫ786 TT genotypes and an increased risk of early-onset stroke, these genotypes might be a marker for African ancestry in general, rather than a marker for increased stroke susceptibility. Third, the association could be caused by a polymorphism in LD with a nearby functional mutation. Finally, NOS3 may contribute causally to the excess early-onset stroke risk among blacks and not among whites because of different environmental exposures or different non-NOS3 genetic backgrounds.
The 2 SNPs associated with stroke in the SPYW population are both located in the 5Ј promoter region of NOS3 and were in strong LD in both the white and black populations. Accordingly, we cannot determine whether 1 of these is a true functional polymorphism. Promoter analysis performed by others suggests that the Ϫ786 SNP may be responsible for a functional change in NOS3 gene expression. 18 The Ϫ786 T allele conveyed a lower level of NOS3 expression than the C allele in the presence of the intron 4 polymorphic sequence. Lower levels of NOS3 expression may lead to reduced protective effects in endothelial cells and thus predispose to stroke.
Haplotype inspection further identified potential risk and protective haplotypes in blacks. The putative risk haplotype, TATxG, suggests that the intron 4 polymorphism is not involved in the effects of NOS3 on stroke susceptibility. However, it is difficult to determine whether the findings are attributable to a true haplotype effect or to the strong LD between the promoter SNPs. The same is true for the protective haplotype, AGCxx, which is independent of the intron 4 and exon 7 polymorphisms.
The present study is limited by its relatively small sample size and by the fact that the cases are heterogeneous in clinically determined etiology. Importantly, this limitation could lead to a reduced ability to identify genetic risk factors but would not account for significant positive associations. The small sample size precluded assessing the association of NOS3 variants stratified by stroke subtypes and limited the power for detecting interactions with other risk factors. This study also has several strengths. First, we examined multiple polymorphisms, as well as estimated haplotypes, in our population, allowing for a more comprehensive evaluation of the gene. Second, our study is the first to examine the association of NOS3 variants with stroke in blacks. Third, this study involved the use of a young stroke population, which may have enhanced our ability to detect a genetic contribution to risk.
In conclusion, our study extends prior work showing the association of NOS3 promoter variants with isolated lacunar stroke in an elderly white population 12 to early onset ischemic stroke of diverse subtypes among blacks. More comprehensive studies of the association between NOS3 genetic variation and both functional correlates and stroke risk in larger, ethnically diverse populations are needed.
Editorial Comment
Are We in Another Unavoidable 'Diagnose and Adios' Era?
None of us in stroke management regret the passage of the "diagnose and adios" era, humorously criticized earlier. We know well that opportunities for stroke management are arising for more definitive studies. A revolution in imaging, the rush to apply results from clinical trials, and attempts to shorten the time frame for action are daily practice because neurologists are interventionists similar to their colleagues in cardiology and emergency medicine. 1 However, with the pace of accumulated data from leisurely approached genetic association studies, we confront the issue of hereditary risk factors.
In this issue of Stroke, Howard et al 2 report on a wellorganized, population-based study in 15-to 44-year-old women. Among the 5 nitric oxide synthase (NOS)3 polymorphisms in 110 cases (46% black) with ischemic stroke and 206 controls (38% black) who were recruited over 4 years, these investigators found that the Ϫ922 G/A and Ϫ786 T/C polymorphisms may be associated with ischemic stroke susceptibility among young black women. Although the small sample size precluded extensive analysis, this study highlights the importance of genetic studies of stroke at a young age in different ethnic groups.
Genetic factors may play a role in cerebral vascular disease and may act via endothelial dysfunction, predominantly in the young. NO synthesized by endothelial NOS is a key mediator of endothelial function, and it could be a candidate gene for stroke. The NOS3 intron 4ab insertion/deletion genotype, but not the Ϫ786 T/C or the G894T genotype, was reported to be associated with isolated lacunar infarction in an English study 3 but not a Japanese study. 4 The NOS3 exon 7 polymorphism (G894T) was reported to not be associated with stroke and transient ischemic attack or the degree of carotid stenosis in patients with cerebrovascular disease. [5] [6] [7] The aforementioned results show that the association between the NOS gene and ischemic stroke is controversial and that there is a possible positive association between the NOS3 intron 4ab insertion/deletion genotype and small-vessel disease in white populations or a possible negative association in other ethnicities.
It is known that the etiology of ischemic stroke in the young is heterogeneous and diverse and that there might be racial differences. 8 Previous reports regarding ischemic stroke in the young showed that blacks, unlike whites, more commonly had the stroke subtype of small-vessel occlusion than large-artery atherosclerosis and that strokes due to other determined and undetermined causes occurred in more than half of young stroke patients in most studies. 8 -11 The finding that the Ϫ922 G/A and Ϫ786 T/C polymorphisms may be associated with ischemic stroke susceptibility among young black women should be confirmed in a large, international, cooperative study. The population-based study design of Howard et al 2 yielded important information, but the phenotype approach to the study of stroke, as designed by Hassan et al, 3 might provide other useful data. Before international cooperative studies are organized, several methodologic problems need to be solved.
We earnestly agree that those studies, which described lacunar infarcts beyond Fisher's early observations, had methodological limitations: sample sizes were generally small; risk factors were inconsistently defined; and studies used a variety of classification methods to define ischemic stroke subtypes. 12 Attempts to refine the stroke subtype classification are worth anticipating. 13 However, efforts to define reproducible subtype classifications of lacunar infarcts or small-vessel occlusion are mandatory for future gene association studies.
Next, the study sample size must be carefully calculated. A small sample size may preclude assessment of any genetic association by stroke subtype, race, or sex and may limit the power of detecting interactions among common risk factors for stroke. Even more, partial digestion might be common in restriction fragment length polymorphism studies; although results of 0% for rare alleles might indicate a very low frequency, they might still exist in the population. Furthermore, conclusions drawn from such "nonexistent" alleles may be misleading. At present, a large, multiethnic, populationbased study to explore differences in genetics by association studies might not be feasible because the parameters to generate hypotheses are lacking. We need more high-quality genetic descriptions from stroke-prone areas of persons with early-onset stroke, such as Asia, Russia, and Africa, with different environmental exposures and different non-NOS3 genetic backgrounds.
We agree that genetics has revolutionized neurologic research. Ironically, however, it is not known how many single-nucleotide polymorphisms would be sufficient for such a project. Genetic studies are time consuming and costly, not to mention the pricey proteomics methods afterward. Genomics might be more appealing for winning grants at universities, an approach that may be useful to the faculty to popularize study proposals but that may not have sufficient power to determine whether a true functional polymorphism exists, let alone a correlation between the polymorphism and patient outcomes.
The results of Howard et al, although inconclusive, point out the many challenges of genetic studies in ethnically different populations. With more understanding of these genetic differences that are not yet modifiable, we may be caught in another unavoidable "diagnose and adios" era. 
